Albert Einstein College of Medicine

Montefiore and Einstein College Introduce Trials for Remdesivir-Baricitinib Combo as a Treatment Option for COVID-19

Medicine & Technology May 27, 2020

Montefiore Health System and Albert Einstein College of Medicine have begun with ACTT 2, a clinical trial using the drug combination remdesivir and baricitinib to treat patients with COVID-19. Researchers are hoping the new drug combo would reduce COVID-19-related inflammation and provide better recovery outcomes for coronavirus patients.

Lack of Sleep Can Trigger Obesity Among Children: Study

Dec 16, 2014

According to a recent study, the lesser the number of hours a child spends sleeping, the higher are the odds that he or she will become obese at a later age.

Albert Einstein College of Medicine

Montefiore and Einstein College Introduce Trials for Remdesivir-Baricitinib Combo as a Treatment Option for COVID-19

Lack of Sleep Can Trigger Obesity Among Children: Study

Most Popular

Extremely Powerful Solar Flare Unleashed by the Sun Triggered Widespread Radio Blackouts Across the Pacific Region

Earth's Magnetic Field Nearly Collapsed 600 Million Years Ago, Sparking Evolution of More Complex Life

Sunscreen Myths Debunked; Expert Warns Against 'Dangerous' Sun Protection Ideas That Only Puts One at Added Risk

Functional Human Brain Cells Made From Salt and Water Mark Significant Step in Iontronic Neuromorphic Computing

Can Animals Give Birth to Twins? How Do They Bring Forth Multiple Offspring?

Recommended Stories

Is Mars Like Earth? NASA Rover Finds Substantial Amounts of Manganese on the Red Planet's Gale Crater

‘Cosmic Glitch’ in Einstein’s Theory of General Relativity Could Be Explained in This New Scientific Tweak [Study]

Unique Exoplanet Found Lurking in Habitable Zone of 2 Stars

Eta Aquarids 2024: Halley's Comet Meteor Shower To Peak This Weekend; Here's How To Watch the Cosmic Light Show